Results 51 to 60 of about 22,335 (252)
Phosphorylation: new star of pathogenesis and treatment in steatotic liver disease
Steatotic liver disease poses a serious threat to human health and has emerged as one of the most significant burdens of chronic liver disease worldwide.
Tiansu Lv +5 more
doaj +1 more source
The myth of the stigma of fatty liver: What does the evidence show?
Recent efforts to reclassify non-alcoholic fatty liver disease (NAFLD) as metabolic dysfunction-associated fatty liver disease (MAFLD) and metabolic dysfunction-associated steatotic liver disease (MASLD) are intended to divert attention to the metabolic ...
Mariana M. Ramírez-Mejía +3 more
doaj +1 more source
The study demonstrates how functional foods, medicinal plants, phytochemicals, bioactive compounds and essential nutrients combat metabolic diseases. It highlights their mechanisms, including antioxidant, anti‐inflammatory, insulin‐sensitising, lipid‐regulating, gut microbiota‐modulating and mitochondrial‐enhancing effects, leading to improved ...
Chinaza Godswill Awuchi +2 more
wiley +1 more source
Steatotic liver diseases are increasing globally, with metabolic dysfunction-associated steatohepatitis potentially causing irreversible fibrosis progression.
Machi Itsubo +4 more
doaj +1 more source
Metabolic dysfunction-associated steatotic liver disease (MASLD) is common, affecting a quarter of the population. The pathogenesis of this disease is multifactorial and has been well known for years. After 40 years of using the binding definition of non-
Iwona Gorczyca-Głowacka +4 more
doaj +1 more source
Harnessing nutrition to combat MASLD: a comprehensive guide to food-based therapeutic strategies
Metabolic dysfunction-associated steatotic liver disease is a growing global health issue linked to obesity, insulin resistance, and metabolic syndrome. Diet plays a key role in its progression and management.
Claudia Reytor-González +6 more
doaj +1 more source
Background: Hyperuricemia and steatotic liver disease are both associated with various comorbidities and mortality. This study was carried out to study the association between hyperuricemia and steatotic liver disease and to assess the impact of the ...
Janis Timsans +7 more
doaj +1 more source
Severe surgically confirmed endometriosis was associated with a lower prevalence of steatotic liver disease than non‐severe disease. Higher estradiol levels may partly explain this inverse hepatic–reproductive association, supporting integrated gynecologic and hepatologic risk assessment.
Jung Hyun Park +5 more
wiley +1 more source
Gene-based therapies for steatotic liver disease
Advances in nucleic acid delivery have positioned the liver as a key target for gene therapy, with adeno-associated virus vectors showing long-term effectiveness in treating hemophilia. Steatotic liver disease (SLD), the most common liver condition globally, primarily results from metabolic dysfunction-associated and alcohol-associated liver diseases ...
Viktoriia, Iakovleva, Ype P, de Jong
openaire +2 more sources
Bile acid metabolism and signaling in human and animal health: A One Health perspective
Bile acids maintain host homeostasis through enterohepatic circulation, microbial transformation, and bile acid receptor signaling, thereby regulating glucose and lipid metabolism, intestinal barrier integrity, and immunity. These effects support human disease intervention and health‐oriented animal production, reducing drug dependence and residue ...
Lei Li +7 more
wiley +1 more source

